VitD3 Supplementation in Patients With Multiple Myeloma

Clinical trial NCT05846880 · RECRUITING

Trial details

NCT number: NCT05846880
Sponsor: Amany Keruakous, MD, MS.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2024-12-01
Primary completion: 2028-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.